Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

OBJECTIVES: We aimed to evaluate the efficacy and safety of combination therapy of Endostar (recombinant human endostatin) and S-1 combined with oxaliplatin (SOX) in patients with advanced gastric cancer. METHODS: In this randomized, controlled trial, 165 late-stage gastric cancer patients were assi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Xu, Rong, Ma, Nan, Wang, Fang, Ma, Lei, Chen, Rui, Chen, Ru, Kebinu, Mijiti, Ma, Lili, Han, Zhongcheng, Ayixiamu, Mayier, Mahemiti, Su, Pengcheng, Naman, Yiming, Jieensi, Haliyazimu, Yang, Haixuan, Adili, Abulizi, Aili, Saiding, Liu, Jiang
التنسيق: Artigo
اللغة:Inglês
منشور في: Dove Medical Press 2013
الموضوعات:
Original Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728266/
https://ncbi.nlm.nih.gov/pubmed/23926435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S46487
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة